SFT — Sopharma Trading AD Balance Sheet
0.000.00%
- BGN196.83m
- BGN425.36m
- BGN1.96bn
- 77
- 98
- 72
- 97
Annual balance sheet for Sopharma Trading AD, fiscal year end - December 31st, BGN millions except per share, conversion factor applied.
2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | |
---|---|---|---|---|---|
Period Length: | — | — | — | — | — |
Source: | ARS | ARS | ARS | ARS | ARS |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Cash | |||||
Cash and Equivalents | |||||
Cash and Short Term Investments | 7.12 | 11.7 | 6.83 | 13.1 | 13.7 |
Net Total Accounts Receivable | |||||
Net Total Receivables | 236 | 209 | 210 | 242 | 282 |
Total Inventory | |||||
Prepaid Expenses | |||||
Total Other Current Assets | |||||
Total Current Assets | 438 | 415 | 416 | 488 | 597 |
Gross Property, Plant And Equipment | |||||
Accumulated Depreciation | |||||
Net Property, Plant And Equipment | 114 | 106 | 111 | 114 | 139 |
Net Goodwill | |||||
Net Intangible Assets | |||||
Long Term Investments | |||||
Long Term Notes Receivable | |||||
Other Long Term Assets | |||||
Total Assets | 617 | 583 | 573 | 643 | 803 |
Accounts Payable | |||||
Accrued Expenses | |||||
Notes Payable / Short Term Debt | |||||
Current Portion of Long Term Debt / Capital Leases | |||||
Total Other Current Liabilities | |||||
Total Current Liabilities | 444 | 401 | 379 | 435 | 513 |
Long Term Debt | |||||
Total Long Term Debt | |||||
Total Debt | |||||
Deferred Income Tax | |||||
Minority Interest | |||||
Total Other Liabilities | |||||
Total Liabilities | 540 | 498 | 478 | 520 | 641 |
Common Stock | |||||
Additional Paid In Capital | |||||
Retained Earnings (Accumulated Deficit) | |||||
Treasury Stock | |||||
Unrealized Gain / Loss | |||||
Total Equity | 76.9 | 84.9 | 94.5 | 123 | 162 |
Total Liabilities & Shareholders' Equity | 617 | 583 | 573 | 643 | 803 |
Total Common Shares Outstanding |